204 related articles for article (PubMed ID: 31717651)
1. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
Nakamae I; Morimoto T; Shima H; Shionyu M; Fujiki H; Yoneda-Kato N; Yokoyama T; Kanaya S; Kakiuchi K; Shirai T; Meiyanto E; Kato JY
Molecules; 2019 Nov; 24(22):. PubMed ID: 31717651
[TBL] [Abstract][Full Text] [Related]
2. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
[TBL] [Abstract][Full Text] [Related]
3. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
4. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y
Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310
[TBL] [Abstract][Full Text] [Related]
5. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth.
Larasati YA; Yoneda-Kato N; Nakamae I; Yokoyama T; Meiyanto E; Kato JY
Sci Rep; 2018 Feb; 8(1):2039. PubMed ID: 29391517
[TBL] [Abstract][Full Text] [Related]
6. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G
Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416
[TBL] [Abstract][Full Text] [Related]
7. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents.
Bognar B; Kuppusamy ML; Madan E; Kalai T; Balog M; Jeko J; Kuppusamy P; Hideg K
Med Chem; 2017; 13(8):761-772. PubMed ID: 28530545
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T
Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids.
Li Y; Gu Z; Zhang C; Li S; Zhang L; Zhou G; Wang S; Zhang J
Eur J Med Chem; 2018 Jan; 144():662-671. PubMed ID: 29289889
[TBL] [Abstract][Full Text] [Related]
11. Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.
Feng C; Xia Y; Zou P; Shen M; Hu J; Ying S; Pan J; Liu Z; Dai X; Zhuge W; Liang G; Ruan Y
Mol Carcinog; 2017 Jul; 56(7):1765-1777. PubMed ID: 28218464
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro.
Leong SW; Chia SL; Abas F; Yusoff K
Eur J Med Chem; 2018 Sep; 157():716-728. PubMed ID: 30138803
[TBL] [Abstract][Full Text] [Related]
13. Differential apoptotic and redox regulatory activities of curcumin and its derivatives.
Mishra S; Kapoor N; Mubarak Ali A; Pardhasaradhi BV; Kumari AL; Khar A; Misra K
Free Radic Biol Med; 2005 May; 38(10):1353-60. PubMed ID: 15855053
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
[TBL] [Abstract][Full Text] [Related]
16. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
17. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
18. Curcumin induces caspase mediated apoptosis in JURKAT cells by disrupting the redox balance.
Gopal PK; Paul M; Paul S
Asian Pac J Cancer Prev; 2014; 15(1):93-100. PubMed ID: 24528086
[TBL] [Abstract][Full Text] [Related]
19. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells.
He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P
J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
